Use of psychoactive medication during pregnancy and possible effects on the fetus and newborn

D. N. Weismann; J. T. Wilson; O. R. Hagino; D. R. Bennett; J. Mulinare; R. Depp; J. Siegfried; S. Mithani; S. M. Macleod; T. Cvetkovich; S. J. Yaffe; C. J. Cote; S. J. Szefler; K. L. Wisner

doi:10.1542/peds.105.4.880

Use of psychoactive medication during pregnancy and possible effects on the fetus and newborn

D. N. Weismann, J. T. Wilson, O. R. Hagino, D. R. Bennett, J. Mulinare, R. Depp, J. Siegfried, S. Mithani, S. M. Macleod, T. Cvetkovich, S. J. Yaffe, C. J. Cote, S. J. Szefler, K. L. Wisner

Psychiatry and Behavioral Sciences

Research output: Contribution to journal › Article › peer-review

165 Scopus citations

Abstract

Psychoactive drugs are those psychotherapeutic drugs used to modify emotions and behavior in the treatment of psychiatric illnesses. This statement will limit its scope to drug selection guidelines for those psychoactive agents used during pregnancy for prevention or treatment of the following common psychiatric disorders: schizophrenia, major depression, bipolar disorder, panic disorder, and obsessive-compulsive disorder. The statement assumes that pharmacologic therapy is needed to manage the psychiatric disorder. This decision requires thoughtful psychiatric and obstetric advice.

Original language	English (US)
Pages (from-to)	880-887
Number of pages	8
Journal	Pediatrics
Volume	105
Issue number	4 I
DOIs	https://doi.org/10.1542/peds.105.4.880
State	Published - 2000

ASJC Scopus subject areas

Pediatrics, Perinatology, and Child Health

Access to Document

10.1542/peds.105.4.880

Cite this

Weismann, D. N., Wilson, J. T., Hagino, O. R., Bennett, D. R., Mulinare, J., Depp, R., Siegfried, J., Mithani, S., Macleod, S. M., Cvetkovich, T., Yaffe, S. J., Cote, C. J., Szefler, S. J., & Wisner, K. L. (2000). Use of psychoactive medication during pregnancy and possible effects on the fetus and newborn. Pediatrics, 105(4 I), 880-887. https://doi.org/10.1542/peds.105.4.880

@article{68955998e77542f3a8da37378cb34867,

title = "Use of psychoactive medication during pregnancy and possible effects on the fetus and newborn",

abstract = "Psychoactive drugs are those psychotherapeutic drugs used to modify emotions and behavior in the treatment of psychiatric illnesses. This statement will limit its scope to drug selection guidelines for those psychoactive agents used during pregnancy for prevention or treatment of the following common psychiatric disorders: schizophrenia, major depression, bipolar disorder, panic disorder, and obsessive-compulsive disorder. The statement assumes that pharmacologic therapy is needed to manage the psychiatric disorder. This decision requires thoughtful psychiatric and obstetric advice.",

author = "Weismann, {D. N.} and Wilson, {J. T.} and Hagino, {O. R.} and Bennett, {D. R.} and J. Mulinare and R. Depp and J. Siegfried and S. Mithani and Macleod, {S. M.} and T. Cvetkovich and Yaffe, {S. J.} and Cote, {C. J.} and Szefler, {S. J.} and Wisner, {K. L.}",

year = "2000",

doi = "10.1542/peds.105.4.880",

language = "English (US)",

volume = "105",

pages = "880--887",

journal = "Pediatrics",

issn = "0031-4005",

publisher = "American Academy of Pediatrics",

number = "4 I",

}

TY - JOUR

T1 - Use of psychoactive medication during pregnancy and possible effects on the fetus and newborn

AU - Weismann, D. N.

AU - Wilson, J. T.

AU - Hagino, O. R.

AU - Bennett, D. R.

AU - Mulinare, J.

AU - Depp, R.

AU - Siegfried, J.

AU - Mithani, S.

AU - Macleod, S. M.

AU - Cvetkovich, T.

AU - Yaffe, S. J.

AU - Cote, C. J.

AU - Szefler, S. J.

AU - Wisner, K. L.

PY - 2000

Y1 - 2000

N2 - Psychoactive drugs are those psychotherapeutic drugs used to modify emotions and behavior in the treatment of psychiatric illnesses. This statement will limit its scope to drug selection guidelines for those psychoactive agents used during pregnancy for prevention or treatment of the following common psychiatric disorders: schizophrenia, major depression, bipolar disorder, panic disorder, and obsessive-compulsive disorder. The statement assumes that pharmacologic therapy is needed to manage the psychiatric disorder. This decision requires thoughtful psychiatric and obstetric advice.

AB - Psychoactive drugs are those psychotherapeutic drugs used to modify emotions and behavior in the treatment of psychiatric illnesses. This statement will limit its scope to drug selection guidelines for those psychoactive agents used during pregnancy for prevention or treatment of the following common psychiatric disorders: schizophrenia, major depression, bipolar disorder, panic disorder, and obsessive-compulsive disorder. The statement assumes that pharmacologic therapy is needed to manage the psychiatric disorder. This decision requires thoughtful psychiatric and obstetric advice.

UR - http://www.scopus.com/inward/record.url?scp=0034051589&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034051589&partnerID=8YFLogxK

U2 - 10.1542/peds.105.4.880

DO - 10.1542/peds.105.4.880

M3 - Article

C2 - 10742343

AN - SCOPUS:0034051589

SN - 0031-4005

VL - 105

SP - 880

EP - 887

JO - Pediatrics

JF - Pediatrics

IS - 4 I

ER -

Use of psychoactive medication during pregnancy and possible effects on the fetus and newborn

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this